The Clorox Company (CLX) स्टॉक विश्लेषण

कंपनी का अवलोकन

The Clorox Company (CLX) is a global manufacturer and marketer of consumer and professional products, operating through four distinct segments: Health and Wellness, Household, Lifestyle, and International. This enterprise functions within the Consumer Defensive sector, specifically the Household & Personal Products industry, providing essential goods that maintain consistent demand regardless of economic cycles. The company demonstrates significant scale with a total market capitalization of $13.13 billion and annual revenue reaching $6.76 billion. Furthermore, the organization employs approximately 7,600 individuals worldwide to execute its business strategy. These valuation and revenue figures indicate that CLX holds a substantial position in the market, possessing a capital base that reflects its established footprint in the household cleaning and wellness industries. The breadth of its product portfolio across multiple segments suggests a diversified revenue stream aimed at mitigating sector-specific risks inherent in the consumer goods landscape.

वित्तीय स्वास्थ्य

The company reported a total revenue of $6.76 billion over the trailing twelve months, generating a net income of $755.00 million and an EBITDA of $1.23 billion. The substantial gap between the $6.76 billion in revenue and the $755.00 million in net income highlights a cost structure where operating expenses, including cost of goods sold and administrative costs, consume a significant portion of top-line sales before reaching the bottom line. In terms of cash generation, the company produced $1.00 billion in free cash flow, which provides critical financial flexibility for capital allocation, debt repayment, or strategic acquisitions without relying solely on external financing. The company maintains a gross margin of 44.2%, reflecting its pricing power and cost control in the manufacturing of cleaning agents. An operating margin of 14.0% indicates efficient management of overhead costs relative to sales volume, while a profit margin of 11.2% demonstrates the final profitability available to shareholders after all expenses. Regarding leverage, the company holds $227.00 million in cash against $3.22 billion in debt, resulting in a debt-to-equity ratio of 9191.43%, which points to a highly leveraged balance sheet structure. The current ratio stands at 0.74, indicating that the company's liquid assets are insufficient to cover its current liabilities, suggesting potential short-term liquidity constraints. Return on Equity is listed at 987.2% and Return on Assets at 11.3%, metrics that reveal complex accounting dynamics regarding the company's equity base and asset utilization efficiency.

मूल्यांकन आकलन

The stock currently trades with a P/E Ratio of 17.61 on a trailing twelve-month basis and a forward P/E of 16.00, implying that the market expects a slight improvement in earnings per share in the upcoming fiscal period. The price-to-book ratio is reported as -104.08, a figure that typically signals a market premium over book value is distorted by significant accumulated retained earnings or accumulated other comprehensive income reducing the equity base. Additional valuation metrics include a price-to-sales ratio of 1.94 and an EV/EBITDA of 13.16, which suggest the market values the company at a multiple roughly equivalent to its sales revenue and earnings power. The 52-week trading range spans from a low of $96.66 to a high of $143.96, providing a context for the stock's recent price volatility. The beta value is 0.65, indicating that the stock exhibits lower price volatility relative to the broader market, often moving less than the S&P 500 during periods of market fluctuation. These valuation multiples and volatility metrics provide a comprehensive view of investor sentiment and risk assessment for this defensive stock.

Growth & Income

Revenue growth year-over-year stands at -0.8%, while earnings growth year-over-year is -16.2%, indicating that earnings are contracting at a significantly faster rate than revenue. This divergence suggests that the company is facing margin compression or cost increases that are outpacing its top-line growth, leading to a sharper decline in profitability than in sales volume. As a dividend payer, the company offers a dividend yield of 4.6% with a payout ratio of 80.5%. The high payout ratio relative to the negative earnings growth implies that the dividend may not be fully sustainable based on current earnings generation, as it is likely being supported by cash flow and retained earnings reserves. The overall growth and income profile for The Clorox Company is characterized by a mature business model that prioritizes dividend distribution over rapid expansion, despite recent headwinds affecting its earnings trajectory.